Quick Takeaways
- AWM Investment Company, Inc. filed SCHEDULE 13G/A for NEUROONE MEDICAL TECHNOLOGIES Corp Common Stock (NMTC).
- Disclosed ownership: 4.8%.
- Date of event: 31 Mar 2025.
AWM Investment Company, Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for NEUROONE MEDICAL TECHNOLOGIES Corp Common Stock (NMTC)
- Filing Manager
- AWM Investment Company, Inc.
- Reporting Manager
- AWM Investment Company, Inc.
- Symbol
- NMTC
- Shares outstanding
- 49,045,146 shares
- Disclosed Ownership
- 2,354,167 shares
- Ownership
- 4.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 09 May 2025, 15:47:21 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"AWM Investment Company, Inc. disclosed 4.8% ownership in NEUROONE MEDICAL TECHNOLOGIES Corp Common Stock (NMTC) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 09 May 2025, 15:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AWM Investment Company, Inc. | 4.8% | 2,354,167 | 2,354,167 | Adam Stettner | Executive Vice President |